doi: 10.3389/fmed.2025.1638981 Received 31 May 2025 Accepted 14 August 2025 Published 10 September 2025 Volume 12 - 2025 Edited by Iain Brownlee, Northumbria University, United Kingdom Reviewed by Qianqian Zhang, Anhui University of Chinese Medicine, China Ion Hobai, Massachusetts General Hospital and Harvard Medical School, United States Updates Copyright 2025 Ukwade, Hernandez, Modi, Raza, Siegel, Nwachukwu, Sarraf, Memon, Booth, Cooper, Boulay and Mutlu
NAC supports production, and liposomal glutathione offers immediate availability
RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist
Clinical studies have shown that individuals using Semaglutide can lose 10-15% of their body weight over several months when combined with a healthy diet and exercise